These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 420215)
1. Patient package inserts and the pharmacist's responsibility. Fink JL Am J Hosp Pharm; 1979 Feb; 36(2):226-9. PubMed ID: 420215 [TBL] [Abstract][Full Text] [Related]
2. The package insert and the pharmacist's liability. Simonsmeier LM Am J Pharm Sci Support Public Health; 1977; 149(3):82-9. PubMed ID: 596428 [No Abstract] [Full Text] [Related]
4. Pharmacists' liability into the year 2000. Lynn NJ; Ellis JM J Am Pharm Assoc (Wash); 1998; 38(6):747-52; quiz 753-4. PubMed ID: 9861793 [TBL] [Abstract][Full Text] [Related]
5. Liability of the pharmacist as a therapeutic consultant. Fink JL Am J Hosp Pharm; 1981 Feb; 38(2):218-22. PubMed ID: 7211885 [TBL] [Abstract][Full Text] [Related]
6. The patient package insert and its legal implications. Cook D Leg Med Q; 1980; 4():258-70. PubMed ID: 10258797 [No Abstract] [Full Text] [Related]
7. Legal implications of preparing and dispensing approved drugs for unlabeled indications. Podell LB Am J Hosp Pharm; 1983 Jan; 40(1):111-3. PubMed ID: 6823981 [TBL] [Abstract][Full Text] [Related]
8. Package inserts, adverse drug reactions, and the physician's liability. Morrell MX Ration Drug Ther; 1975 Aug; 9(8):1-6. PubMed ID: 1144773 [No Abstract] [Full Text] [Related]
9. Drug product selection and the law. Fink JL Contemp Pharm Pract; 1979; 2(3):128-31. PubMed ID: 10242846 [TBL] [Abstract][Full Text] [Related]
10. Food and Drug Administration--Prescription drug products; patient package inserts requirements. Final rule. Fed Regist; 1980 Sep; 45(179 Pt 2):60754-84. PubMed ID: 10248285 [TBL] [Abstract][Full Text] [Related]
11. Product selection: community formularies and legal aspects. The pharmacist's responsibility in product selection. Kanig JL Am J Pharm Sci Support Public Health; 1972; 144(5):133-8. PubMed ID: 4641165 [No Abstract] [Full Text] [Related]
12. Prescription drug products; patient package insert requirements--Food and Drug Administration. Final rule. Fed Regist; 1981 Jan; 46(1):28-30. PubMed ID: 10324121 [TBL] [Abstract][Full Text] [Related]
13. Whose liability is it? The pharmacist on trial. Am Pharm; 1994; NS34 Suppl 1():1-16; quiz 17-9. PubMed ID: 7726096 [No Abstract] [Full Text] [Related]
14. A literature search on pharmacokinetic drug interactions of statins and analysis of how such interactions are reflected in package inserts in Japan. Saito M; Hirata-Koizumi M; Urano T; Miyake S; Hasegawa R J Clin Pharm Ther; 2005 Feb; 30(1):21-37. PubMed ID: 15659001 [TBL] [Abstract][Full Text] [Related]
15. The pharmacist's role in thrombolytic therapy. Nappi JM Am J Hosp Pharm; 1990 Sep; 47(9 Suppl 2):S20-5. PubMed ID: 2206052 [TBL] [Abstract][Full Text] [Related]
16. Prescription drug products that require patient package inserts; ampicillin and phenytoin--Food and Drug Administration. Final rule. Fed Regist; 1981 Jan; 46(1):28. PubMed ID: 10249520 [TBL] [Abstract][Full Text] [Related]
17. Computers, OBRA 90 and the pharmacist's duty to warn. Cacciatore GG Spec Law Dig Health Care Law; 1997 Jul; (221):9-25. PubMed ID: 10168619 [No Abstract] [Full Text] [Related]
18. The paperless labeling initiative: a proof-of-concept study. Ruchalski C Ann Pharmacother; 2004; 38(7-8):1178-82. PubMed ID: 15187216 [TBL] [Abstract][Full Text] [Related]
19. Legal implications of the pharmacist's expanded clinical roles: a challenge to the clinical pharmacist's competencies. Moore RC; Mikeal RL; Brewer BF; Burton SF Contemp Pharm Pract; 1979; 2(3):132-5. PubMed ID: 10297530 [TBL] [Abstract][Full Text] [Related]
20. Legal implications of preparing and dispensing drugs under conditions not in a product's official labeling. Mandl FL; Greenberg RB Am J Hosp Pharm; 1976 Aug; 33(8):814-6. PubMed ID: 949065 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]